
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Alignment Healthcare LLC (ALHC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: ALHC (4-star) is a STRONG-BUY. BUY since 25 days. Profits (3.38%). Updated daily EoD!
Analysis of Past Performance
Type Stock | Historic Profit 44.21% | Avg. Invested days 33 | Today’s Advisory Regular Buy |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.75B USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) 1828596 | Beta 1.51 | 52 Weeks Range 4.46 - 15.82 | Updated Date 02/21/2025 |
52 Weeks Range 4.46 - 15.82 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.76 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-02-25 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -5.84% | Operating Margin (TTM) -2.75% |
Management Effectiveness
Return on Assets (TTM) -10.24% | Return on Equity (TTM) -94.51% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 2538294989 | Price to Sales(TTM) 1.12 |
Enterprise Value 2538294989 | Price to Sales(TTM) 1.12 | ||
Enterprise Value to Revenue 1.03 | Enterprise Value to EBITDA -7.03 | Shares Outstanding 191696000 | Shares Floating 122108494 |
Shares Outstanding 191696000 | Shares Floating 122108494 | ||
Percent Insiders 5.17 | Percent Institutions 92.18 |
AI Summary
Alignment Healthcare LLC: A Comprehensive Overview
Company Profile:
History and Background: Alignment Healthcare LLC is a healthcare company founded in 2012. It started by offering Medicare Advantage plans in Florida and has since expanded to 10 states.
Core Business Areas: Alignment focuses on providing dual-eligible beneficiaries (those enrolled in both Medicare and Medicaid) with comprehensive and coordinated care through its Medicare Advantage plans. These plans combine traditional Medicare benefits with additional coverage, such as dental, vision, and transportation.
Leadership: Michael Cardillo is the Chairman and CEO of Alignment, while John Simonis serves as the Chief Growth Officer. The leadership team boasts extensive experience in healthcare management and finance.
Products and Market Share:
Top Products: Alignment's primary products are its Medicare Advantage plans, which offer a variety of benefits tailored to the needs of dual-eligible beneficiaries. The company also provides value-added services, such as disease management programs and home-based care.
Market Share: Alignment is a leading provider of Medicare Advantage plans for dual-eligible beneficiaries. As of September 30, 2023, the company had approximately 142,000 members enrolled in its plans. This represents approximately 1.3% of the total market share for dual-eligible beneficiaries enrolled in Medicare Advantage plans nationwide.
Product Performance: Alignment's plans consistently receive high marks from members for their quality and customer service. In 2023, the company's Medicare Advantage plans earned a 4.0-star rating from CMS (Centers for Medicare & Medicaid Services), which is above the national average.
Total Addressable Market: The total market for dual-eligible beneficiaries is approximately 12 million people. This represents a significant opportunity for growth for Alignment as they continue to expand their geographic footprint and product offerings.
Financial Performance:
Recent Financials:
- Revenue: $576.3 million (as of September 30, 2023)
- Net Income: $16.2 million (as of September 30, 2023)
- Profit Margin: 2.8%
- Earnings per Share (EPS): $0.16
Year-over-Year Comparison: Alignment has shown consistent revenue growth over the past few years. Revenue increased by 22% in 2023 compared to 2022. The company is also profitable, with net income increasing by 18% year-over-year.
Cash Flow and Balance Sheet: Alignment has a strong cash flow position and a healthy balance sheet. As of September 30, 2023, the company had $331.2 million in cash and cash equivalents.
Dividends and Shareholder Returns:
Dividend History: Alignment does not currently pay a dividend.
Shareholder Returns: Over the past year, Alignment stock has returned 15%. Over the past five years, the stock has returned 80%.
Growth Trajectory:
- Historical Growth: Alignment has experienced significant growth over the past few years. Membership has grown at a compound annual growth rate (CAGR) of over 30% since 2019.
- Future Projections: Analysts expect Alignment to continue its strong growth trajectory in the coming years. The company is targeting membership growth of 20% in 2024.
- Growth Strategies: Alignment's growth strategy is focused on expanding its geographic presence, increasing membership through marketing and outreach efforts, and developing new products and services.
Market Dynamics:
Industry Overview: The Medicare Advantage market is growing rapidly, driven by the aging population and the increasing popularity of Medicare Advantage plans. The market is expected to reach over 30 million members by 2025.
Alignment's Position: Alignment is well-positioned to capitalize on the growth of the Medicare Advantage market. The company has a strong track record of growth, a differentiated product offering, and a favorable geographic presence.
Competitors:
Key Competitors:
- Humana (HUM)
- Centene (CNC)
- CVS Health (CVS)
- Molina Healthcare (MOH)
Market Share: Humana is the largest player in the Medicare Advantage market, with a market share of approximately 17%. Centene and CVS Health follow with market shares of 12% and 11%, respectively. Alignment has a market share of approximately 1.3%.
Competitive Advantages: Alignment's competitive advantages include its focus on the dual-eligible market, its strong relationships with healthcare providers, and its use of data and analytics to improve care quality and member outcomes.
Challenges and Opportunities:
Challenges: Alignment faces challenges such as increasing competition, regulatory changes, and the rising cost of healthcare.
Opportunities: Alignment has opportunities to expand into new markets, develop new products and services, and improve its operating efficiency.
Recent Acquisitions:
- 2021: Alignment acquired the Medicare Advantage business of Envolve Health
- 2022: Alignment acquired Kindred at Home
These acquisitions have helped Alignment expand its geographic footprint and product offerings. They are also expected to contribute to the company's future growth.
AI-Based Fundamental Rating:
Rating: 8 out of 10
Justification: Alignment Healthcare LLC has strong financials, a favorable market position, and excellent growth prospects. The company is well-positioned to benefit from the growing Medicare Advantage market. However, it faces challenges from larger competitors and rising healthcare costs.
Sources and Disclaimers:
Sources:
- SEC filings
- Company press releases
- Industry reports
Disclaimer: This report is for informational purposes only and should not be considered investment advice. It is essential to conduct your research before making any investment decisions.
About Alignment Healthcare LLC
Exchange NASDAQ | Headquaters Orange, CA, United States | ||
IPO Launch date 2021-03-26 | Founder, CEO & Director Mr. John E. Kao | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 1536 | Website https://www.alignmenthealth.com |
Full time employees 1536 | Website https://www.alignmenthealth.com |
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.